What Is NAD+ and Why Is Everyone Talking About It?

Written by NorthPeptide Research Team

For laboratory and research use only. Not for human consumption.

Five years ago, NAD+ was something you’d find in a biochemistry textbook somewhere between “glycolysis” and “electron transport chain.” Today, it’s on podcast ads, supplement labels, and the tip of every biohacker’s tongue. David Sinclair put it on the map, Joe Rogan amplified the signal, and suddenly everyone wants to know: what is this molecule, and does it actually matter?

Short answer: yes, it matters. It’s one of the most important molecules in your body. But the story is more nuanced than the marketing suggests.

NAD+ in 60 Seconds

NAD+ stands for nicotinamide adenine dinucleotide. It’s a coenzyme — a helper molecule — found in every living cell. Without it, you’d be dead in about 30 seconds. That’s not hyperbole. NAD+ is required for:

• Turning food into energy: It’s a key player in glycolysis, the citric acid cycle, and oxidative phosphorylation — basically, every pathway your cells use to produce ATP (energy)
• DNA repair: An enzyme called PARP uses NAD+ as fuel to fix broken DNA strands. No NAD+, no repair.
• Gene regulation: Sirtuins — a family of proteins linked to longevity — require NAD+ to function. They regulate everything from inflammation to circadian rhythm to fat metabolism.
• Cell signaling: NAD+ is consumed by CD38 and other enzymes involved in calcium signaling and immune function.

Think of NAD+ as cellular currency. Your cells are constantly spending it and making it. Problems arise when spending outpaces production.

The Age Problem

Here’s the finding that launched a thousand supplements: NAD+ levels decline with age. Significantly.

Research by Massudi et al. (2012) measured NAD+ in human skin tissue across age groups and found levels dropped by roughly 50% between ages 20 and 60. Zhu et al. (2015) found similar declines in mouse tissues. By old age, NAD+ levels can be a fraction of what they were in youth.

Why does this happen? Several factors compound:

• CD38 goes up: CD38 is an enzyme that breaks down NAD+. Its expression increases with age and chronic inflammation, essentially draining the NAD+ pool faster.
• PARP demand increases: As DNA damage accumulates with age, PARP enzymes consume more NAD+ trying to keep up with repairs.
• Production slows: The biosynthetic pathways that make NAD+ (especially the salvage pathway using NAMPT) become less efficient.
• Inflammation: Chronic low-grade inflammation (sometimes called “inflammaging”) drives CD38 expression and increases NAD+ consumption.

The result is a vicious cycle: less NAD+ means less sirtuin activity, less DNA repair, and more cellular dysfunction — which creates more inflammation and oxidative stress, which consumes more NAD+.

What Happens When You Restore NAD+ Levels?

This is where the research gets genuinely exciting. In animal studies, boosting NAD+ levels has produced some remarkable results:

The Mouse Studies

• Aging reversal (Zhang et al., 2016): Old mice given the NAD+ precursor NMN showed improved blood vessel density and exercise capacity. Their endurance on a treadmill essentially doubled — matching levels seen in young mice.
• Muscle function (Gomes et al., 2013): One-week NMN treatment reversed age-related mitochondrial dysfunction in old mice. The muscles of treated old mice became biochemically similar to young mice on several measures.
• Neurodegeneration (Wang et al., 2016): NAD+ supplementation improved cognitive function and reduced neuroinflammation in Alzheimer’s disease mouse models.
• Metabolism (Yoshino et al., 2011): NMN improved insulin sensitivity and lipid metabolism in diet-induced obesity models.

But Wait — What About Humans?

This is where we need to be honest: the human data is still early.

Several clinical trials have been completed or are underway:

• NMN safety trials: Doses up to 1,200 mg/day have been shown to be safe and to increase blood NAD+ metabolites in healthy adults (Yi et al., 2023).
• NR (nicotinamide riboside) trials: Multiple studies confirm NR raises NAD+ levels in humans. The CHROMADIET trial and others showed measurable increases in blood NAD+ with 300-1,000 mg daily doses.
• Functional outcomes: This is where things get murkier. While NAD+ levels clearly go up, the dramatic improvements seen in mice (reversed aging, doubled endurance) haven’t been replicated in human trials yet. Some studies show modest improvements in markers like blood pressure and arterial stiffness; others show no significant functional change.

The gap between mouse results and human results isn’t unusual in biomedical research. Mice live 2-3 years, so age-related changes are compressed. A 50% NAD+ decline that takes decades in humans happens over months in mice, potentially making the intervention more dramatic.

The Precursor Debate: NMN vs NR vs Direct NAD+

You can’t just swallow an NAD+ pill and expect it to get into your cells — the molecule is too large to cross cell membranes efficiently. So researchers study precursors that cells can convert into NAD+:

• NMN (Nicotinamide Mononucleotide): Converted to NAD+ in one enzymatic step (by NMNAT enzymes). The precursor with the most animal research. Can be taken orally — recent discovery of the Slc12a8 transporter suggests direct NMN uptake in the gut.
• NR (Nicotinamide Riboside): Converted to NMN first, then to NAD+. Commercially available as “Niagen.” Has the most human clinical trial data.
• Niacin/Nicotinamide: The oldest and cheapest precursors. Effective at raising NAD+ but with side effects (flushing with niacin) and at high doses may inhibit sirtuins (with nicotinamide).
• Direct NAD+ (injectable): Bypasses the oral absorption problem entirely. Used in IV infusion research and in injectable research preparations. This is where research-grade NAD+ from suppliers like NorthPeptide comes in — enabling direct NAD+ study without conversion pathway variables.

The Sirtuin Connection

Much of the excitement around NAD+ comes from its connection to sirtuins — particularly SIRT1. Here’s why sirtuins matter:

Sirtuins are a family of seven enzymes (SIRT1-7) that regulate gene expression by removing acetyl groups from proteins (deacetylation). They’re sometimes called “longevity genes” because activating them in various organisms extends lifespan. SIRT1 activation mimics the effects of caloric restriction — the only intervention consistently shown to extend lifespan across species from yeast to primates.

But here’s the key connection: sirtuins literally cannot function without NAD+. NAD+ isn’t just a cofactor — it’s a co-substrate that gets consumed in every deacetylation reaction. So when NAD+ levels drop, sirtuin activity drops. When sirtuin activity drops, the gene regulation programs that maintain cellular health start to deteriorate.

This is the core of the NAD+ aging hypothesis: age-related NAD+ decline → reduced sirtuin activity → impaired cellular maintenance → accelerated aging.

What the Critics Say

Not everyone is sold on the NAD+ narrative. Fair criticisms include:

• “Mouse results don’t always translate.” True. Many interventions that reverse aging in mice fail in humans. The biology is similar but not identical.
• “The supplement industry got ahead of the science.” Also true. NMN and NR supplements are selling hundreds of millions of dollars annually based largely on animal data. The human evidence, while growing, doesn’t yet support the strongest claims being made.
• “CD38 inhibition might matter more than boosting NAD+.” An interesting counterargument: if the problem is excessive NAD+ consumption by CD38, maybe the solution is reducing CD38 activity rather than just making more NAD+. Some researchers are exploring this angle.
• “Cancer cells need NAD+ too.” This is a legitimate concern. Cancer cells have high metabolic demands and upregulate NAD+ biosynthesis. Whether systemically boosting NAD+ could theoretically fuel tumor growth is an active area of investigation.

Where the Research Is Heading

The NAD+ field is maturing rapidly. Key areas to watch:

• Tissue-specific delivery: Getting NAD+ or its precursors to specific organs (brain, heart, muscle) rather than just raising blood levels
• Combination approaches: NAD+ boosting alongside sirtuin activators, CD38 inhibitors, or senolytic compounds
• Biomarker development: Better ways to measure intracellular NAD+ levels in living humans (current blood tests may not reflect tissue levels)
• Long-term human trials: Multi-year studies measuring actual health outcomes, not just NAD+ levels

The Honest Summary

NAD+ is genuinely important. Its decline with age is real and well-documented. The animal data supporting NAD+ restoration is compelling. The human data is promising but early. The supplements are probably ahead of the proof.

If you’re a researcher, NAD+ biology is one of the most fertile areas in aging science. If you’re a consumer, the honest answer is: we don’t know yet whether boosting NAD+ in otherwise healthy humans produces meaningful health improvements. The science is exciting, but it’s not finished.

Related Research

• NAD+ Complete Research Guide
• Epithalon Research Guide — telomere and aging research
• MOTS-c Research Guide — mitochondrial peptide for metabolic aging
• SS-31 Research Guide — mitochondrial targeted peptide

---

Summary of Key Research References

Study	Year	Type	Focus	Reference
Bhasin et al.	2023	Review	NAD+ in aging biology: potential applications and unknowns	PMC12102727
Freeberg et al.	2023	Review	Dietary supplementation with NAD+-boosting compounds in humans	PMC10692436
Conlon et al.	2021	Review	The role of NAD+ in regenerative medicine	PMC9512238
Kim et al.	2020	Review	Mitochondrial-derived peptides in aging and age-related diseases	PMC8190245
Mohtashami et al.	2022	Review	MOTS-c: mitochondrial derived peptide in human aging	PMC9570330
Campbell et al.	2018	Experimental	Improving mitochondrial function with SS-31 reverses age-related redox stress	PMC6588449
Zheng et al.	2023	Review	MOTS-c as a promising mitochondrial-derived peptide for therapeutic exploitation	PMC9905433

All products mentioned are sold strictly for laboratory and research use. Not for human consumption.